Increased YKL-40 but Not C-Reactive Protein Levels in Patients with Alzheimer’s Disease
Neuroinflammation is a common feature in Alzheimer’s (AD) and Parkinson’s (PD) disease. In the last few decades, a testable hypothesis was proposed that protein-unfolding events might occur due to neuroinflammatory cascades involving alterations in the crosstalk between glial cells and neurons. Here...
Main Authors: | Víctor Antonio Blanco-Palmero, Marcos Rubio-Fernández, Desireé Antequera, Alberto Villarejo-Galende, José Antonio Molina, Isidro Ferrer, Fernando Bartolome, Eva Carro |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/9/9/1094 |
Similar Items
-
YKL-40 and the Cellular Metabolic Profile in Parkinson’s Disease
by: Maria Gevezova, et al.
Published: (2023-11-01) -
YKL-40 as a Potential Biomarker for the Differential Diagnosis of Alzheimer’s Disease
by: Ioannis Mavroudis, et al.
Published: (2021-12-01) -
YKL-40 and cytokines - a New Diagnostic Constellation in Rheumatoid Arthritis?
by: Kazakova Maria H., et al.
Published: (2017-03-01) -
Elevation in circulating YKL-40 concentration in patients with cerebrovascular disease
by: Xue Xu, et al.
Published: (2014-08-01) -
Serum YKL-40 as a potential biomarker of inflammation in psoriasis
by: Anna Baran, et al.
Published: (2018-01-01)